US Stem Cell (OTCMKTS:USRM) Stock Price Up 2%
Shares of US Stem Cell Inc (OTCMKTS:USRM) rose 2% during trading on Thursday . The stock traded as high as $0.01 and last traded at $0.01, approximately 1,744,500 shares changed hands during mid-day trading. An increase of 262% from the average daily volume of 482,097 shares. The stock had previously closed at $0.01.
The firm’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01.
US Stem Cell Company Profile (OTCMKTS:USRM)
U.S. Stem Cell, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States and internationally. Its lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of acute myocardial infarction, chronic heart ischemia, and lower limb ischemia.
Read More: How Do Mutual Funds Work?
Receive News & Ratings for US Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for US Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.